Position in CADL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,072,388
+$3,488,935 QoQ
Shares Held
492,465
+52.4% QoQ
Ownership
0.644%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 138 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. CADL ranks #164 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in CADL
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,072,388 | 492,465 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $1,583,453 | 323,154 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,669,223 | 295,438 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,564,551 | 306,775 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,456,585 | 287,863 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,330,777 | 235,536 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,432,381 | 165,021 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,100,282 | 158,771 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $269,359 | 43,445 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $30,821 | 19,507 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $28,836 | 19,617 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $18,047 | 19,617 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $24,717 | 19,617 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $26,482 | 19,617 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $25,924 | 14,483 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $45,476 | 14,483 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $46,924 | 14,483 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $68,485 | 13,455 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $105,218 | 13,455 | Shares | Defined | 2022-02-08 | |
| No filing history on record for this holder in this stock. | ||||||